Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44

Benzinga Newsdesk www.benzinga.com Neutral 49.4%

Neg 0% Neu 49.4% Pos 0%

Wedbush analyst Laura Chico initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Outperform rating and announces Price Target of $44.